Invitrogen™ Kit ELISA of G-CSF (CSF3) mouse

Ref.: BL-RE-091947Manufacturer ref.: EMCSF3X10 10 x 96 tests
€4,815.00 excl. VAT

G-CSF is a natural cytokine that stimulates the production and antibacterial function of neutrophils and monocytes. Human G-CSF is a 18.8-kDa protein containing 175 amino acid residues and a soluble isoform of the...

Accession number
P09920
Dose range
0.62 to 150 pg/ml
Sensitivity of the dosage
0.5 pg/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

G-CSF is a natural cytokine that stimulates the production and antibacterial function of neutrophils and monocytes. Human G-CSF is a 18.8-kDa protein containing 175 amino acid residues and a soluble isoform of the...

G-CSF is a natural cytokine that stimulates the production and antibacterial function of neutrophils and monocytes. Human G-CSF is a 18.8 kDa protein containing 175 amino acid residues and a soluble isoform of the G-CSF receptor has been described. Pleiotropic cytokine is produced by activated monocytes, macrophages, endothelial cells, fibroblasts, astrocytes, osteoblasts, and bone marrow cells. G-CSF has been shown to have specific effects on the proliferation, differentiation and activation of haematopoietic cells. G-CSF is also expressed by different transformed cells such as cancer cells and myeloblast leukemic cells. The G-CSF is encoded by two distinct sequences of the DNA, giving a large-scale high-activity isoform of the G-CSF and a small-scale low-activity isoform. G-CSF is highly conserved among species and has been shown to perform its biological functions through interaction with its receptor, expressed on the surface of hematopoietic progenitors, neutrophil granulocytes and certain cell lines of carcinoma. The clinical use of G-CSF has been approved for several therapeutic applications, for the treatment of neonatal infections, the treatment of acute myocardial infarction, granulocyte transfusion in patients with neutropenia, serious infections and septicaemia, treatment of chronic autoimmune neutropenia, treatment of acute myeloid leukaemia, Sweet syndrome and AIDS. In addition, G-CSF has been shown to be a protein marker for different carcinomas and protein dysfunction, Kostmann's syndrome.

Sensitivity

Sensitivity of the dosage: 0.5 pg/ml.

Measurement range

Dose range: 0.62 to 150 pg/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Reproducibility

Coefficient of intradose variation < 10%, interdose < 12%.

Target

Target: G-CSF.

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17758103
Specifications
Accession numberP09920
Dose range0.62 to 150 pg/ml
Sensitivity of the dosage0.5 pg/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)12985
Gene symbol(s)Csf3
Coefficient of inter-dose variation< 12%
Coefficient of intra-dose variation< 10%
Contents of kits96-well pre-coated plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity10 x 96 tests
Regulatory statusRUO
TargetG-CSF
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 5 μl-Serum, 5 μl-Surnatant, 100 μl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EMCSF3X10
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.